Active

C.D. PHARMA

Switched

BE0461479280

Rechtspersoon Private limited company 1 establishment

Allée de la Tour-Renard 15, 1400 Nivelles

Active for

28 year, 11 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -1,539

▼ 13% vs 2024

Profit

Caution

€ -10,408

▼ 2% vs 2024

Debts

High

€ 245,323

▲ 2% vs 2024

C.D. PHARMA from Nivelles, company number BE0461479280, closed financial year 2025 with a result of € -10,408 after tax. For that financial year C.D. PHARMA recorded a gross margin of € -1,539 and equity of € 25,306. Compared with financial year 2024, the result moved from € -10,158 to € -10,408. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What happened at C.D. PHARMA?

What happened at C.D. PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 10,408. Source: NBB ↗
  • New establishment in Nivelles. KBO
  • Start of the company according to the CBE. KBO

In short

From € 8,810 loss in 2021 to € 10,408 loss in 2025.

A new publication or filing at C.D. PHARMA? We notify you, reason included.

Follow C.D. PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

PHILIPPE DENIS
C.D. PHARMA
EXO PHARMA 99.5%

Behind C.D. PHARMA is PHILIPPE DENIS. It owns 99.5% of EXO PHARMA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

PHILIPPE DENIS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Allée de la Tour-Renard 15

1400 Nivelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0461.479.280
VAT number
BE 0461.479.280
Registered office
Allée de la Tour-Renard 15, 1400 Nivelles
Names & denominations
C.D. PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
19 September 1997
Peppol
Not registered

Frequently asked questions

What is the enterprise number of C.D. PHARMA?
The enterprise number of C.D. PHARMA is BE0461479280.
What is the address of C.D. PHARMA?
The registered office of C.D. PHARMA is located at Allée de la Tour-Renard 15, 1400 Nivelles.
When was C.D. PHARMA founded?
C.D. PHARMA was founded on 19 September 1997.
Does C.D. PHARMA have a website?
No website is currently known for C.D. PHARMA.
How much profit did C.D. PHARMA make in 2025?
C.D. PHARMA recorded a loss after taxes of € 10,408 in financial year 2025.
What is the revenue of C.D. PHARMA?
As a small company, C.D. PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,539.
Where can I find the annual accounts of C.D. PHARMA?
C.D. PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of C.D. PHARMA?
According to the 2025 annual accounts, the directors of C.D. PHARMA are: PHILIPPE DENIS.
Who owns C.D. PHARMA?
Behind C.D. PHARMA is PHILIPPE DENIS. It owns 99.5% of EXO PHARMA itself.